Claude Failed to Produce Scorpion Antivenom in Citrini Research Experiment

Investment research firm Citrini Research partnered with Anthropic to test whether an unreleased version of Claude could help create scorpion antivenom. According to experts cited by The Verge, the AI generated some promising starting points but nothing approaching a usable drug. Citrini acknowledged that none of its team had expertise in AI as applied to biology. The firm nonetheless attempted to develop a drug from scratch and published a blog post describing the outcome.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.




Discussion (0)
Log in to join the discussion and vote.
Log in